Predicting outcomes in CNS lymphoma with ctDNA
BLOOD（2024）
摘要
In this issue of Blood, Heger and colleagues describe a novel tool for predicting clinical outcome in central nervous system (CNS) lymphomas that is based on clinical features, radiographic response to induction, and circulating tumor DNA (ctDNA) detection.1
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要